Literature DB >> 26032753

Variation in warfarin prescribing and dosing in the UK: a national survey of anticoagulation clinics.

A Stewart1, A Ganguli1, R FitzGerald1, M Pirmohamed1.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Clinical practice in the initiation, prescribing, dosing and monitoring of warfarin in the UK varies, but this has not been adequately documented. The objective was to undertake a survey on current clinical practice in this area, and how it compares with national guidelines that have been developed by the British Committee for Standards in Haematology.
METHODS: A national online survey of anticoagulation clinics was performed using Survey Monkey(®) . The survey was designed to capture data for prescribing, dosing and monitoring of anticoagulation with warfarin.
RESULTS: Of 85 clinics who responded to the survey, most were run by secondary care (68%), facilitated by specialist nurses (58%) and followed standard guidelines for the management of warfarin (87%). The majority of clinics indicated their target international normalized ratio (INR) for patients with atrial fibrillation (AF) (69/73; 94·5%) was between 2·0 and 3·0, but the indicated target INR for mechanical heart valves was more variable. Initiation and loading dosing regimens were a major source of variability with uncertainty surrounding individual patient factors such as age, ethnicity and BMI. WHAT IS NEW AND
CONCLUSIONS: Current practice amongst UK anticoagulation clinics largely follows current national guidelines but better guidance on dosing, taking into account factors that determine interindividual variability in daily warfarin dose requirements would improve and standardize oral anticoagulation with warfarin.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  anticoagulation; pharmacovigilance; prescribing; survey; warfarin

Mesh:

Substances:

Year:  2015        PMID: 26032753     DOI: 10.1111/jcpt.12291

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Morbidity and mortality associated with the interaction of miconazole oral gel and warfarin.

Authors:  M N Pemberton
Journal:  Br Dent J       Date:  2018-07-27       Impact factor: 1.626

Review 2.  Pharmacogenetics to guide cardiovascular drug therapy.

Authors:  Julio D Duarte; Larisa H Cavallari
Journal:  Nat Rev Cardiol       Date:  2021-05-05       Impact factor: 32.419

3.  Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?

Authors:  Reyes Serrano Teruel; Geir Thue; Svein Ivar Fylkesnes; Sverre Sandberg; Ann Helen Kristoffersen
Journal:  Scand J Prim Health Care       Date:  2017-08-04       Impact factor: 2.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.